Search results
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 8 hours agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
Marijuana Reclassification Puts Politics and Profits Ahead of Public Health
Newsweek· 6 hours agoThe first major change to federal marijuana laws may be on the horizon now that it has been leaked...
TIME100 Health: David Ricks
Time via AOL· 15 hours agoDavid Ricks Credit - David Paul Morris—Bloomberg/Getty Images It’s hard for a major pharmaceutical company to launch one successful novel drug& ...
At least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says
CNN.com· 12 hours agoDrugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy,...
Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday
Motley Fool via Yahoo Finance· 2 days agoBut perhaps the most onerous headwind that will be reversed by rescheduling is...companies will no...
These Are the Drugs America Is Running Short On
247wallst.com· 3 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
London Drugs closes stores after cyber incident
Supermarket News· 1 day agoThe cybersecurity incident was the second breach at a major North American healthcare company in recent months following an attack in February at Change...
Earnings call: Genmab reports strong Q1 growth, plans ProfoundBio acquisition By Investing.com
Investing.com· 4 hours agoThe company's CEO, Jan van de Winkel, announced the proposed acquisition of ProfoundBio, which is...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 18 hours agoLilly expects to file for U.S. approval of the drug in treating heart failure with preserved ejection fraction (HFpEF) later this year. ...Zepbound are,...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 21 hours agoLast year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some...expenditure...
